Company: NKLR
Filing Date: 2025-09-16
Form Type: 424B3
Source: 0001213900-25-087981
Chunk: 216

Company: Terra Innovatum Global N.V.
Filing Date: 2025-09-16
Form: 424B3
Chunk 216
---
 first years of operations in the different markets considered. Secondary research also assessed the commercial viability of SOLO compared to current and projected energy prices, deriving the markets, in terms of geography and sectors, where SOLO reactors can be competitive compared to current energy providers from the grid or alternative known SMR/MMR solutions. These market analysis has allowed to evaluate the conservative number of units which would need to be produced, delivered and commissioned after commercial licensing. These market analyses also allowed us to evaluate the number of commercial contracts customers could reasonably be expected to sign before and after the licensing process tentative completion. The analysis of the supply chain and early engagement with suppliers led to identify long lead time items which would need to be ordered several months before the reactor assembly. These analysis allowed to evaluate what would be the conservative production ramp -upTerra Innovatum and its contracted manufacturers would be able to achieve. Based on the current discussions with potential contract manufacturers in US and in Europe, we expect to have an annual capacity for 400 SOLOs. It is estimated to take approximately 2 years to increase the capacity to 800 – 1,000 units which could require co -investment. The schedule was provided to GSR III in the fourth quarter of 2024 to begin evaluating future orders with suppliers of key components that have long lead -times. The target deliveries included in the illustrative schedule assumed that regulatory permitting approvals have been obtained to permit construction and operation of the facilities. However, the regulatory permitting process, including necessary NRC approvals and licensing, is a lengthy, complex process and projected timelines could vary materially from the actual time necessary to obtain all required approvals. While there is some possibility of an expedited approval process for fast reactor technology, there is presently no clear path for expedited permitting. See the risk factors in the section entitled “ Risk Factors” beginning on page 23 of this proxy statement/prospectus. Conflicts of Interest Potential investors should be aware of the following potential conflicts of interest: •GSR III’s officers and directors are not required to, and will not, commit their full time to GSR III’s affairs, which may result in a conflict of interest in allocating their time between GSR III’s operations and GSR III’s search for a business combination and their other businesses and commitments. GSR III does not intend to have any full -timeemployees prior to the completion of its initial business combination. Each of GSR III’s officers is engaged in several other business endeavors for which he may be entitled to substantial compensation, and